Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study-Reference-Cited by-同舟云学术

Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study

Published:2021-04-14 Issue:10 Volume:40 Page:3971-3978
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Di Cola Ilenia,Bruno Federico,Berardicurti Onorina,Monti Riccardo,Conforti Alessandro,Di Sibio Alessandra,Pavlych Viktoriya,Masciocchi Carlo,Barile Antonio,Cipriani Paola,Ruscitti Piero^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-021-05727-2.pdf

Reference24 articles.

1. Giacomelli R, Ruscitti P, Shoenfeld Y (2018) A comprehensive review on adult onset Still's disease. J Autoimmun 93:24–36. https://doi.org/10.1016/j.jaut.2018.07.018

2. Feist E, Mitrovic S, Fautrel B (2018) Mechanisms, biomarkers and targets for adult-onset Still's disease. Nat Rev Rheumatol 14:603–618. https://doi.org/10.1038/s41584-018-0081-x

3. Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, Guggino G, Carubbi F, Berardicurti O, Di Benedetto P, Valenti M, Triolo G, Valentini G, Giacomelli R (2016) Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med 14:194. https://doi.org/10.1186/s12916-016-0738-8

4. Gerfaud-Valentin M, Jamilloux Y, Iwaz J, Sève P (2014) Adult-onset Still's disease. Autoimmun Rev 13:708–722. https://doi.org/10.1016/j.autrev.2014.01.058

5. Ruscitti P, Cipriani P, Liakouli V, Guggino G, Carubbi F, Berardicurti O, Ciccia F, Giacomelli R (2019) Managing adult-onset Still's disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study. Medicine (Baltimore) 98:e15123. https://doi.org/10.1097/MD.0000000000015123

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry;Arthritis & Rheumatology;2024-05-15

2. The latest advances in the use of biological DMARDs to treat Still’s disease;Expert Opinion on Biological Therapy;2024-02

3. Childhood-Onset SLE and Neonatal Lupus Erythematosus;A Clinician's Pearls & Myths in Rheumatology;2023

4. Perspectives on the use of non-biological pharmacotherapy for adult-onset Still’s disease;Expert Opinion on Pharmacotherapy;2022-09-22

5. Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study;Medicine;2022-07-15